PCM
IMGN

Perkins Capital Management’s Immunogen Inc IMGN Stock Holding History

Perkins Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,400
Closed -$308K – 96
2023
Q4 		$308K Sell
10,400
-1,700
-14% -$33.9K 0.26% 72
2023
Q3 		$192K Sell
12,100
-5,100
-30% -$84.8K 0.19% 80
2023
Q2 		$325K Sell
17,200
-4,300
-20% -$50.8K 0.28% 73
2023
Q1 		$83K Buy
21,500
+9,000
+72% +$38.4K 0.08% 89
2022
Q4 		$62K Buy
+12,500
New +$67.8K 0.07% 89

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Perkins Capital Management's IMGN Position: Q1 2024 in Review

Perkins Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 10,400 shares — an estimated $308K sold.

Perkins Capital Management first reported a position in IMGN in Q4 2022 and held it in 5 quarters. The position peaked at $325K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Perkins Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Perkins Capital Management sold 10,400 Immunogen Inc shares in Q1 2024, an estimated $308K.
  • Perkins Capital Management first reported a position in Immunogen Inc in Q4 2022 and held it in 5 quarters.
  • Perkins Capital Management's Immunogen Inc position peaked at $325K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Perkins Capital Management's 13F filing for Q1 2024, filed 9 May 2024.